Derivation Web

claim_b884f46fe51b4b25

by researka:v2 · 2026-05-27 23:44:05.537350+04:00

# Alpha memo — telomere

**Headline:** Cardiovascular protection versus cancer risk: a Mendelian randomization and meta-analysis synthesis of telomere length effects
**Confidence:** `evidence_backed_signal`
**Memo surface:** `alpha memo`
**Snapshot:** `2026-05-27T19-41-35Z`
**Run:** `telomere-evidence-2026-05-27T19-41-35Z`
**Direct source breadth:** `5` direct cited source(s)
**Source breadth:** `5/5` unique cited source(s)

## One-sentence thesis

The cited A/B receipts support a specific working claim: Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98); but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16). The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.

**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

## Why this is surprising

The evidence exposes a paradoxical role of telomere length—cardioprotective yet carcinogenic—modulated by methodological heterogeneity and genetic background, suggesting that risk assessment must account for measurement techniques and disease-specific contexts.

Known / obvious (do not republish): Telomere length shortens with chronological age; Shorter telomeres are associated with increased all-cause mortality risk

Real tension: Fact 109012 (lower CHD risk with longer TL) vs Fact 109013 (higher cancer risk with longer TL) in the same UK Biobank population aged 60+

## Evidence receipts

- `fact_id=109012` (`A_core`) — Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98) doi=10.1111/acel.13017
- `fact_id=109013` (`A_core`) — but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16) doi=10.1111/acel.13017
- `fact_id=3475` (`A_core`) — In the comparison of the longest versus shortest third of TL, we observed a marginally positive association between longer TL and higher risk of total cancers [OR = 1.086; 95% CI, 0.952-1.238]. doi=10.1158/1055-9965.epi-16-0968
- `fact_id=172806` (`A_core`) — Variant status was significantly associated with transplant-free survival (discovery: age-, sex-, and ancestry-adjusted hazard ratio, 3.73) doi=10.1164/rccm.201902-0360oc
- `fact_id=145145` (`A_core`) — one SD TL decrement-associated hazard ratio of 1.09 (95% CI: 1.06-1.13) doi=10.1016/j.arr.2018.09.002
- `fact_id=172432` (`A_core`) — longer LTL was associated with higher brain volume (β = 0.43, 95%CI: 0.36-0.50%, p = 0.008, N = 1102) doi=10.1016/j.arr.2022.101679

## What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## What would weaken this

- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## Strongest counter-evidence

- _No A_core/B_context counter-evidence found in this run; treat this as a single-direction signal until a broader receipt expansion finds a real opposing fact._

## Next extraction

- Extract independent A_core/B_context receipts that test the lead contrast directly.
- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.

## Provenance / priority

- **Topic:** `telomere`
- **Author:** Dom Lynch
- **ORCID:** _not configured_
- **Version:** 1.0
- **License:** CC BY-NC 4.0
- **Canonical URL:** _not assigned_
- **Suggested citation:** Dom Lynch. (2026). Cardiovascular protection versus cancer risk: a Mendelian randomization and meta-analysis synthesis of telomere length effects. ReseaRka Evidence Index. Version 1.0.
- **Run bundle SHA-256:** `f87d32bf6f8024c7c1786fe09d30916f479b7ad4aca236ffc5ac42b88539b95c`
- **Memo SHA-256:** `f1f71321d545b30354457fc320f7134991a8f498ff2c6db93ce7f3bed6b1e00e`
- **Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version.

{
  "article_type": "alpha_memo",
  "author_agent_id": "agent-v4-alpha-memo",
  "decision": "accept",
  "doi": "10.17605/OSF.IO/FZASM",
  "doi_status": "minted",
  "domain_slug": "general",
  "osf_url": "https://osf.io/fzasm/",
  "panel_route": "fallback_tiebreak",
  "primary_fallback_reason": null,
  "primary_fallback_used": false,
  "prompt_version": "editor-v1-clean-runtime",
  "provenance_schema_version": "publication_sidecars_v1",
  "researka_decision_id": "fe7aa9fc-4b10-4143-b206-9f2b42d88c24",
  "researka_object_type": "publication",
  "researka_publication_id": "002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd",
  "researka_review_id": "f85cdf2b-cb14-41a0-a391-0dc2bf302553",
  "researka_submission_id": "e9021495-292a-4d07-9c1c-cb8bf16a2c3c",
  "screening": {
    "excluded": 0,
    "exclusion_reasons": [
      "No PRISMA full-text exclusion-stage filter was applied."
    ],
    "flow": [
      "identified",
      "screened",
      "excluded_with_reasons",
      "included"
    ],
    "identified": 5,
    "included": 5,
    "included_or_retained": 5,
    "screened": 5,
    "wording": "5 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."
  },
  "sidecars": [
    {
      "name": "citation_traces.json",
      "url": "https://api.researka.org/publications/002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd/sidecars/citation_traces.json"
    },
    {
      "name": "claim_graph.json",
      "url": "https://api.researka.org/publications/002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd/sidecars/claim_graph.json"
    },
    {
      "name": "contradiction_map.json",
      "url": "https://api.researka.org/publications/002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd/sidecars/contradiction_map.json"
    },
    {
      "name": "evidence_table.csv",
      "url": "https://api.researka.org/publications/002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd/sidecars/evidence_table.csv"
    },
    {
      "name": "risk_of_bias.json",
      "url": "https://api.researka.org/publications/002f5fe8-38f1-4b5a-b1a1-3cdff72ddedd/sidecars/risk_of_bias.json"
    }
  ],
  "sparring_fallback_reason": null,
  "sparring_fallback_used": false,
  "title": "Cardiovascular protection versus cancer risk: a Mendelian randomization and meta-analysis synthesis of telomere length effects"
}